Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Lactobacillus rhamnosus GG vs Saline for UTI Prevention in SCI
NCT05230511Phase 2Recruiting
- Sponsor
- MedStar Health Research Institute
- Start
- Jun 2022
- Primary completion
- Jul 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Lactobacillus rhamnosus GG in urinary tract infection (UTI), sponsored by MedStar Health Research Institute. Started Jun 2022; status: recruiting.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT05230511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05230511.